General Information of Drug (ID: DMOFCRY)

Drug Name
SEROTONIN Drug Info
Synonyms
serotonin; 5-HYDROXYTRYPTAMINE; 3-(2-Aminoethyl)-1H-indol-5-ol; 50-67-9; Enteramine; 5-HT; Serotonine; Thrombotonin; Thrombocytin; Antemovis; Ds substance; Hippophain; Antemoqua; Substance DS; Substanz DS; 1H-Indol-5-ol, 3-(2-aminoethyl)-; 5-Hta; Tryptamine, 5-hydroxy-; 3-(2-Aminoethyl)indol-5-ol; Enteramin; UNII-333DO1RDJY; Indol-5-ol, 3-(2-aminoethyl)-; 5-Hydroxy-3-(beta-aminoethyl)indole; 3-(beta-Aminoethyl)-5-hydroxyindole; EINECS 200-058-9; 3-(2-Amino-ethyl)-1H-indol-5-ol; BRN 0143524; 333DO1RDJY; CHEBI:28790
Cross-matching ID
PubChem CID
5202
ChEBI ID
CHEMBL39
CAS Number
CAS 50-67-9
TTD Drug ID
D0F6CD
VARIDT Drug ID
DR00189
INTEDE Drug ID
DR1961

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
DNA replication 2.11 0.00e+0 34/36 (94.44%) MCM4;PCNA;RPA3;...
Cell cycle 2.11 0.00e+0 110/124 (88.71%) CDC20;MYC;TFDP1;...
Spliceosome 2.09 0.00e+0 101/150 (67.33%) LSM6;SRSF1;HNRNPK;...
Progesterone-mediated oocyte maturation 1.85 1.36e-2 75/100 (75%) CCNA2;PLK1;AURKA;...
Oocyte meiosis 1.76 3.26e-2 90/129 (69.77%) CDC20;PLK1;AURKA;...
Mitophagy -1.74 4.74e-2 56/68 (82.35%) CSNK2A1;BCL2L1;OPTN;...
Amino sugar and nucleotide sugar metabolism -1.77 3.17e-2 38/48 (79.17%) HKDC1;PMM1;GMPPA;...
Pentose phosphate pathway -1.79 3.08e-2 25/30 (83.33%) ALDOC;TALDO1;PGD;...
Glycerophospholipid metabolism -1.84 2.03e-2 71/98 (72.45%) PLPP1;MBOAT7;CDS2;...
Steroid biosynthesis -1.85 2.31e-2 19/20 (95%) NSDHL;LIPA;LSS;...
Sphingolipid metabolism -1.90 9.24e-3 32/49 (65.31%) CERS4;SPHK1;SPHK2;...
Lysosome -2.00 4.62e-3 115/128 (89.84%) M6PR;ARSA;AGA;...
Ferroptosis -2.13 0.00e+0 36/41 (87.8%) GCLC;ACSL3;ACSL1;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 24H
Breast epithelium
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF-10A CVCL_0598 Homo sapiens 12uM - 100uM 48H
Fibroblast
Nasopharyngeal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
FIBRNPC CVCL_UK07 Homo sapiens 10uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 0.08uM - 100uM 24H, 48H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.08uM - 20uM 24H